Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 165 entries
View as:

Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02934464 Org: User:
Start: 12/31/16 End: 12/31/21 Due: 12/31/22

Xpert Bladder Monitor: a Non-Invasive Follow-Up Tool for Detecting Relapse in High Grade or High Risk Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06751667 Org: User:
Start: 01/01/25 End: 01/01/32 Due: 01/01/33

Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14

Phase: N/A Priority: Normal
NCT ID: NCT02860936 Org: User:
Start: 06/30/15 End: 06/30/19 Due: 06/30/20

NAC Sparing Mastectomy After Neo-adjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02471742 Org: User:
Start: 01/31/04 End: 05/31/15 Due: 05/31/16

Peritoneal Lavage Liquid Biopsy in Patients With Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04943406 Org: User:
Start: 05/08/20 End: 05/31/25 Due: 05/31/26

Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03294122 Org: User:
Start: 02/02/17 End: 12/31/19 Due: 12/31/20

Cyberknife After Breast Conservative Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02896322 Org: User:
Start: 06/30/13 End: 06/30/18 Due: 06/30/19

Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04248998 Org: User:
Start: 05/05/20 End: 05/01/24 Due: 05/01/25

Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial

Phase: N/A Priority: Normal
NCT ID: NCT02176369 Org: User:
Start: 02/28/13 End: 10/27/18 Due: 10/27/19

Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06986486 Org: User:
Start: 06/01/25 End: 01/01/30 Due: 01/01/31

Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00910572 Org: User:
Start: 07/31/07 End: 05/31/10 Due: 05/31/11

Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02867852 Org: User:
Start: 03/31/15 End: 05/31/20 Due: 05/31/21

Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05031975 Org: User:
Start: 05/02/22 End: 06/01/24 Due: 06/01/25

Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS)

Phase: N/A Priority: Normal
NCT ID: NCT06361784 Org: User:
Start: 03/29/24 End: 03/29/29 Due: 03/29/30

Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr

Phase: N/A Priority: Normal
NCT ID: NCT06799624 Org: User:
Start: 01/21/25 End: 01/31/28 Due: 01/31/29

Radiomics and Molecular Classification in Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06963385 Org: User:
Start: 01/15/21 End: 12/31/26 Due: 12/31/27

TARC After alloSCT in Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02069639 Org: User:
Start: 11/30/13 End: 01/31/14 Due: 01/31/15

Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03539328 Org: User:
Start: 06/30/18 End: 04/30/22 Due: 04/30/23

Preemptive Treatment With XONRID to Reduce Radiation Induced Dermatitis in Head and Neck Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02261181 Org: User:
Start: 01/31/15 End: 01/31/19 Due: 01/31/20

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01172912 Org: User:
Start: 10/31/10 End: - Due: -

Screening and Multiple Intervention on Lung Epidemics

Phase: N/A Priority: Normal
NCT ID: NCT03654105 Org: User:
Start: 07/23/19 End: 12/31/26 Due: 12/31/27

Multimodality Treatments of HPV-related Lesions of the Female Genital Tract

Phase: N/A Priority: Normal
NCT ID: NCT05938192 Org: User:
Start: 07/15/20 End: 12/30/28 Due: 12/30/29

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

Phase: N/A Priority: Normal
NCT ID: NCT02099175 Org: User:
Start: 11/30/13 End: 01/31/24 Due: 01/31/25

Colorectal Cancer Detection by Means of Optical Fluoroscopy

Phase: N/A Priority: Normal
NCT ID: NCT01286064 Org: User:
Start: 10/31/10 End: 04/30/11 Due: 04/30/12

Cancer Anesthesia and Frailty

Phase: N/A Priority: Normal
NCT ID: NCT03575416 Org: User:
Start: 07/03/18 End: 11/01/18 Due: 11/01/19